These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28361809)

  • 1. Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy.
    Caserta CA; Mele A; Surace P; Ferrigno L; Amante A; Messineo A; Vacalebre C; Amato F; Baldassarre D; Amato M; Marcucci F; Zuin M
    Ann Ist Super Sanita; 2017; 53(1):77-81. PubMed ID: 28361809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.
    Caserta CA; Pendino GM; Amante A; Vacalebre C; Fiorillo MT; Surace P; Messineo A; Surace M; Alicante S; Cotichini R; Zuin M; Rosmini F; Mele A; Marcucci F
    Am J Epidemiol; 2010 Jun; 171(11):1195-202. PubMed ID: 20457571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of gamma-glutamyl transferase as a suitable simple biomarker of the cardiovascular risk in children with non-alcoholic fatty liver disease.
    Bobrus-Chociej A; Flisiak-Jackiewicz M; Daniluk U; Wojtkowska M; Kłusek-Oksiuta M; Tarasów E; Lebensztejn D
    Acta Biochim Pol; 2018 Oct; 65(4):539-544. PubMed ID: 30380561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    Gummesson A; Strömberg U; Schmidt C; Kullberg J; Angerås O; Lindgren S; Hjelmgren O; Torén K; Rosengren A; Fagerberg B; Brandberg J; Bergström G
    PLoS One; 2018; 13(8):e0202666. PubMed ID: 30133541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
    Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
    Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk.
    Merino J; Sala-Vila A; Plana N; Girona J; Vallve JC; Ibarretxe D; Ros E; Ferré R; Heras M; Masana L
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):261-7. PubMed ID: 26817937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients.
    Gentili A; Daviddi G; De Vuono S; Ricci MA; Di Filippo F; Alaeddin A; Mannarino MR; Boni M; Vaudo G; Lupattelli G
    Dig Liver Dis; 2016 Aug; 48(8):904-8. PubMed ID: 27160697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD?
    Gianotti G; Cenni A; Bianchi G; Masetti M; Zappoli P; Muscari A; Zoli M;
    Arch Gerontol Geriatr; 2014; 58(2):188-95. PubMed ID: 24268461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by
    Lee HJ; Lee CH; Kim S; Hwang SY; Hong HC; Choi HY; Chung HS; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Metabolism; 2017 Feb; 67():72-79. PubMed ID: 28081780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T
    Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.